Thiola (Tiopronin) Patent Expiration, LOE Window & CMS Spending

Thiola (Tiopronin) by Mission Pharmacal: FDA Orange Book LOE 2026-06-28, 1 AB generics, $5.0M 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorMission Pharmacal
FDA Application & PathwayN019569 (NDA)
Exclusivity / Cliff HorizonImmediate Cliff (2025-2027)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2026-06-28
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors1
2024 CMS Total Public Spend$5.0M
2024 Medicare Part D Spend$3.6M
2024 Medicaid Spend$1.3M
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel